These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 1315571)
21. [Experiences with plasmapheresis in the treatment of vascular rejection following kidney transplantation]. Eismann R; Konert J; Langkopf B Z Urol Nephrol; 1990 Jan; 83(1):9-12. PubMed ID: 2330764 [TBL] [Abstract][Full Text] [Related]
22. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study. Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929 [TBL] [Abstract][Full Text] [Related]
23. Consistencies and controversies in the application of the International Society for Heart and Lung Transplantation working formulation for heart transplant biopsy specimens. Rapamycin Cardiac Rejection Treatment Trial Pathologists. Winters GL; McManus BM J Heart Lung Transplant; 1996 Jul; 15(7):728-35. PubMed ID: 8820790 [TBL] [Abstract][Full Text] [Related]
24. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy. Cantarovich M; Latter DA; Loertscher R Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721 [TBL] [Abstract][Full Text] [Related]
25. Pulmonary capillaritis: a possible histologic form of acute pulmonary allograft rejection. Badesch DB; Zamora M; Fullerton D; Weill D; Tuder R; Grover F; Schwarz MI J Heart Lung Transplant; 1998 Apr; 17(4):415-22. PubMed ID: 9588587 [TBL] [Abstract][Full Text] [Related]
26. Photopheresis versus corticosteroids in the therapy of heart transplant rejection. Preliminary clinical report. Costanzo-Nordin MR; Hubbell EA; O'Sullivan EJ; Johnson MR; Mullen GM; Heroux AL; Kao WG; McManus BM; Pifarre R; Robinson JA Circulation; 1992 Nov; 86(5 Suppl):II242-50. PubMed ID: 1424007 [TBL] [Abstract][Full Text] [Related]
28. Heart transplantation in neonates and in children. Backer CL; Zales VR; Idriss FS; Lynch P; Crawford S; Benson DW; Mavroudis C J Heart Lung Transplant; 1992; 11(2 Pt 1):311-9. PubMed ID: 1576137 [TBL] [Abstract][Full Text] [Related]
29. Late allograft failure after heart transplantation: 2 unusual cases. Boilson BA; Miller DV; Pereira NL J Heart Lung Transplant; 2008 Sep; 27(9):1050-4. PubMed ID: 18765202 [TBL] [Abstract][Full Text] [Related]
30. Treatment of acute vascular rejection with immunoadsorption. Olivari MT; May CB; Johnson NA; Ring WS; Stephens MK Circulation; 1994 Nov; 90(5 Pt 2):II70-3. PubMed ID: 7955287 [TBL] [Abstract][Full Text] [Related]
31. Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation. McVicar JP; Kowdley KV; Emond MJ; Barr D; Marsh CL; Carithers RL; Perkins JD Clin Transplant; 1997 Aug; 11(4):328-33. PubMed ID: 9267724 [TBL] [Abstract][Full Text] [Related]
32. Acute vascular rejection of the coronary arteries in human heart transplantation: pathology and correlations with immunosuppression and cytomegalovirus infection. Normann SJ; Salomon DR; Leelachaikul P; Khan SR; Staples ED; Alexander JA; Mayfield WR; Knauf DG; Sadler LA; Selman S J Heart Lung Transplant; 1991; 10(5 Pt 1):674-87. PubMed ID: 1659903 [TBL] [Abstract][Full Text] [Related]
33. Diagnostic validity of hepatocyte growth factor as marker for rejection in the follow-up of patients after heart transplantation. Zwirska-Korczala K; ZakliczyĆski M; Berdowska A; Zembala M; Jochem J; Gajewska K J Heart Lung Transplant; 2005 Apr; 24(4):411-5. PubMed ID: 15797741 [TBL] [Abstract][Full Text] [Related]
34. Treatment of cardiac allograft rejection with intravenous corticosteroids. Miller LW J Heart Transplant; 1990; 9(3 Pt 2):283-7. PubMed ID: 2355284 [TBL] [Abstract][Full Text] [Related]
35. Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy. Holt DB; Lublin DM; Phelan DL; Boslaugh SE; Gandhi SK; Huddleston CB; Saffitz JE; Canter CE J Heart Lung Transplant; 2007 Sep; 26(9):876-82. PubMed ID: 17845925 [TBL] [Abstract][Full Text] [Related]
36. Donor-derived human leukocyte antigen class I proteins in the serum of heart transplant recipients. DeVito-Haynes LD; Jankowska-Gan E; Heisey D; Jutte NH; Balk AH; Weimar W; Claas FH; Warner TF; Mentzer RM; Love RB; Burlingham WJ J Heart Lung Transplant; 1996 Oct; 15(10):1012-26. PubMed ID: 8913919 [TBL] [Abstract][Full Text] [Related]
37. How successful is OKT3 rescue therapy for steroid-resistant acute rejection episodes after heart transplantation? Wagner FM; Reichenspurner H; Uberfuhr P; Kur F; Kaulbach HG; Meiser BM; Ziegler U; Reichart B J Heart Lung Transplant; 1994; 13(3):438-42; discussion 442-3. PubMed ID: 8061020 [TBL] [Abstract][Full Text] [Related]
38. Cardiac transplantation: role of endomyocardial biopsy and immunosuppressive agents. Eiswirth CC; Smart FW J La State Med Soc; 1993 May; 145(5):203-6. PubMed ID: 8340682 [TBL] [Abstract][Full Text] [Related]
39. Reversible severe vascular rejection after plasmapheresis. Mourani C; Mallat S; Akatcherian C; Moussalli A J Med Liban; 1998; 46(1):40-2. PubMed ID: 9795522 [TBL] [Abstract][Full Text] [Related]
40. VCAM-1 and E-selectin expression during cytomegalovirus infection in post-transplant myocardial biopsies. Allen MD; King C; MacDonald TO; Himes V Clin Transplant; 1996 Dec; 10(6 Pt 1):528-37. PubMed ID: 8996774 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]